Brief: Pure Biologics Gets 4.5 Mln Zloty Advance From Poland's NCBR
02/09/2020 10:43
Sept 2 (Reuters) - Pure Biologics SA PUR1.WA :
* GETS SECOND ADVANCE FROM POLAND'S NATIONAL CENTRE FOR
RESEARCH
AND DEVELOPMENT IN AMOUNT OF 4.5 MILLION ZLOTYS FOR R+D OF PB001
PURE BODY DRUG
Source text for Eikon: ID:nEM7T4tfYa
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects